SEC Filings for Ayala Pharmaceuticals, Inc.
SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Form Type: SCHEDULE 13G
Filing Date: 2025-04-16
View Filing
15-12G - Securities registration termination [Section 12(g)]
Form Type: 15-12G
Filing Date: 2024-05-09
View Filing
10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Form Type: 10-K/A
Filing Date: 2024-04-26
View Filing
8-K/A [Amend] - Current report
Form Type: 8-K/A
Filing Date: 2024-04-19
View Filing
10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form Type: 10-K
Filing Date: 2024-04-16
View Filing
S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Form Type: S-8 POS
Filing Date: 2024-04-15
View Filing
S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Form Type: S-8 POS
Filing Date: 2024-04-15
View Filing
S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Form Type: S-8 POS
Filing Date: 2024-04-15
View Filing
S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Form Type: S-8 POS
Filing Date: 2024-04-15
View Filing
S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Form Type: S-8 POS
Filing Date: 2024-04-15
View Filing
